AKT1 and breast carcinoma: Our team demonstrated, for the first time, that GABARAP inhibited EMT-related breast cancer tumor progression in a cell model, an animal model and human breast cancer tissue samples, and the mechanism may involve direct regulation of the AKT/mTOR pathway.